Author: admin

Financing led by Novo Holdings, RA Capital Management, Royalty Pharma, SR One, and TPG Life Sciences Innovations, with participation from 16 additional new and existing investors Proceeds will be used, in part, to establish Ph3 and commercial-scale GMP manufacturing capacity that will accelerate cli

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: